Literature DB >> 11829339

Neuronal migration, cerebral cortical development, and cerebral cortical anomalies.

Daniela Pilz1, Neil Stoodley, Jeffrey A Golden.   

Abstract

Cerebral cortical malformations are relatively common anomalies identified by neuroimaging and pathologically in patients with epilepsy and mental retardation. A disruption in neuronal migration during central nervous system development has been postulated as the pathogenesis for many of these disorders. Recently, the cell migration hypothesis has been proven accurate for lissencephaly, subcortical band heterotopia, and periventricular nodular heterotopia. Furthermore, advances in cellular and molecular biology have begun elucidating the fundamental mechanisms underlying these migration disorders. These data have resulted in redefining and recategorizing specific malformations based on their molecular genetic abnormality. In this review we shall discuss the current understanding of neuronal migration in the developing cerebral cortex, the evaluation of these patients, and attempt to describe the pathogenesis for several well-characterized human disorders of cell migration.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11829339     DOI: 10.1093/jnen/61.1.1

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  13 in total

Review 1.  Neurodevelopmental outcome in congenital diaphragmatic hernia: Evaluation, predictors and outcome.

Authors:  Enrico Danzer; Stephen S Kim
Journal:  World J Clin Pediatr       Date:  2014-08-08

2.  Diffusion tensor imaging in lissencephaly.

Authors:  Nancy Rollins; Tony Reyes; Jon Chia
Journal:  AJNR Am J Neuroradiol       Date:  2005 Jun-Jul       Impact factor: 3.825

3.  Dystroglycan on radial glia end feet is required for pial basement membrane integrity and columnar organization of the developing cerebral cortex.

Authors:  Timothy D Myshrall; Steven A Moore; Adam P Ostendorf; Jakob S Satz; Tom Kowalczyk; Huy Nguyen; Ray A M Daza; Charmaine Lau; Kevin P Campbell; Robert F Hevner
Journal:  J Neuropathol Exp Neurol       Date:  2012-12       Impact factor: 3.685

Review 4.  Cortical dysplasia: neuropathological aspects.

Authors:  Christian H Rickert
Journal:  Childs Nerv Syst       Date:  2006-06-09       Impact factor: 1.475

5.  Lis1 is necessary for normal non-radial migration of inhibitory interneurons.

Authors:  Matthew F McManus; Ilya M Nasrallah; MacLean M Pancoast; Anthony Wynshaw-Boris; Jeffrey A Golden
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

6.  Disruption of neural progenitors along the ventricular and subventricular zones in periventricular heterotopia.

Authors:  Russell J Ferland; Luis Federico Batiz; Jason Neal; Gewei Lian; Elizabeth Bundock; Jie Lu; Yi-Chun Hsiao; Rachel Diamond; Davide Mei; Alison H Banham; Philip J Brown; Charles R Vanderburg; Jeffrey Joseph; Jonathan L Hecht; Rebecca Folkerth; Renzo Guerrini; Christopher A Walsh; Esteban M Rodriguez; Volney L Sheen
Journal:  Hum Mol Genet       Date:  2008-11-07       Impact factor: 6.150

Review 7.  [Congenital malformations of the cerebral brain. 1: Malformations of the cerebral cortex].

Authors:  B Ertl-Wagner; C Rummeny; M F Reiser
Journal:  Radiologe       Date:  2003-11       Impact factor: 0.635

8.  Identification of brain malformations: neuropathological approach.

Authors:  Férechté Encha-Razavi
Journal:  Childs Nerv Syst       Date:  2003-06-11       Impact factor: 1.475

9.  Sall1 regulates cortical neurogenesis and laminar fate specification in mice: implications for neural abnormalities in Townes-Brocks syndrome.

Authors:  Susan J Harrison; Ryuichi Nishinakamura; Kevin R Jones; A Paula Monaghan
Journal:  Dis Model Mech       Date:  2011-12-22       Impact factor: 5.758

10.  Hereditary lissencephaly and cerebellar hypoplasia in Churra lambs.

Authors:  Valentín Pérez; Aroa Suárez-Vega; Miguel Fuertes; Julio Benavides; Laetitia Delgado; M Carmen Ferreras; Juan José Arranz
Journal:  BMC Vet Res       Date:  2013-08-09       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.